
18/07/2025
🧬 Innovative Stem Cell Therapy for Type I Diabetes: Immunomodulatory and Regenerative Approach 🧪
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the destruction of pancreatic beta cells, which are responsible for insulin production.
Mesenchymal stem cells (MSCs) represent an emerging therapeutic strategy due to their ability to:
🔹 Modulate the immune response, helping to slow autoimmune activity
🔹 Reduce inflammation, minimizing pancreatic tissue damage with direct Intra Pancreatic Injections
🔹 Support regeneration, potentially promoting restoration of islet function
🔹 Improve glycemic homeostasis and reduce dependence on exogenous insulin
At Stem Cell Healing Institute (SCHI), we implement advanced cellular therapy protocols focused on improving metabolic function and enhancing patient quality of life.